Tubers of Corydalis cava were extracted with ethanol and fractionated using n-hexane, chloroform and ethanol. Repeated column chromatography, preparative TLC and crystallization led to the isolation of fifteen isoquinoline alkaloids. The chemical structures of the isolated compounds were determined on the basis of spectroscopic techniques and by comparison with literature data. All isolated compounds were tested for human blood acetylcholinesterase (HuAChE) and human plasma butyrylcholinesterase (HuBuChE) inhibitory activity. (+)-Canadaline inhibited acetylcholinesterase as well as butyrylcholinesterase in a dose-dependent manner with IC50 values of 20.1 ± 1.1 μM and 85.2 ± 3.2 μM, respectively. (+)-Canadine, with an IC50 value of 12.4 ± 0.9 μM, was the most potent inhibitor of acetylcholinesterase, whilst (±)-corycavidine and (+)-bulbocapnine were effective inhibitors of butyrylcholinesterase with IC50 values of 46.2 ± 2.4 uM and 67.0 ± 2.1 μM, respectively. The other isolated alkaloids were considered inactive (IC50 > 100 μM).
ParkS.Y. (2010) Potential therapeutic agents against Alzheimer's disease from natural sources. Archives of Pharmacal Research, 33, 1589–1609; (b) Mattson MP, Maudsley S, Martin BA. (2004) A neural signaling triumvirate that influences ageing and age-related disease: insulin/IGF-1, BDNF and serotonin. Ageing Research Reviews, 3, 445-464; (c) Iqbal K, Liu F, Gong CX, Alonso AC, Grundke-Iqbal I. (2009) Mechanism of tau-induced neurodegeneration. Acta Neuropathologica, 118, 53-69; (d) Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR. (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science, 215, 1237-1239; (e) Lahiri DK, Farlow MR, Greig NH, Sambamurti K. (2002) Current drug targets for Alzheimer's disease treatment. Drug Development Research, 56, 267-281; (f) Greig NH, Lahiri DK, Sambamurti K. (2002) Butyrylcholinesterase: an important new target in Alzheimer's disease therapy. International Psychogeriatrics, 14, 77-91; (g) Maelicke A, Samochocki M, Jostok R, A, Ludwig J, Albuquerque EX, Zerlin M. (2001) Allosteric sensitization of nicotinic receptors by galanthamine, a new treatment strategy for the Alzheimer's disease. Biological Psychiatry, 26, 279-288; (h) Lleó A. (2007) Current therapeutic options for Alzheimer's disease. Current Genomics, 8, 550-558; (i) Recanatini M, Valenti P. (2004) Acetylcholinesterase inhibitors as a starting point towards improved Alzheimer's disease therapeutics. Current Pharmaceutical Design, 10, 3157-3166.
2.
BerkovS., BastidaJ., NikolovaM., ViladomatF., CodinaC. (2008) Rapid TLC/GC-MS identification of acetylcholinesterase inhibitors in alkaloid extracts. Phytochemical Analysis, 19, 411–419; (b) Hostettmann K, Borloz A, Urbain A, Marston A. (2006) Natural product inhibitors of acetylcholinesterase. Current Organic Chemistry, 10, 825-847; (c) Mukherjee PK, Kumar V, Mal M, Houghton PJ. (2007) Acetylcholinesterase inhibitors from plants. Phytomedicine, 14, 289-300.
3.
HoughtonP.J., RenY., HowesM.J. (2006) Acetylcholinesterase inhibitors from plants and fungi. Natural Products Reports, 23, 181–199; (b) Preininger V, Thakur RS, Šantavý F. (1976) Isolation and chemistry of alkaloids from plants of the family Papaveraceae LXVII: Corydalis cava (L.) Sch. et K. (C. tuberosa DC). Journal of Pharmaceutical Sciences, 65, 294-296; (c) Slavík J, Slavíková L. (1979) Alkaloids from Corydalis cava (L.) Schw. et Koerte. Collection of Czechoslovak Chemical Communications, 44, 2261-2274; (d) Preininger V. (1986). In: The Alkaloids, Brossi A (Ed.) Vol. 29, Academic Press, New York, 1-98; (e) Meyer A, Imming P. (2008) R(-)-Canadaline as first secoberbine alkaloid from Corydalis cava. Phytochemistry Letters, 1, 168-170; (f) Adsersen A, Kjølbye A, Dall O, Jäger AK. (2007) Acetylcholinesterase and butyrylcholinesterase inhibitory compounds from Corydalis cava Schweigg. & Kort. Journal of Ethnopharmacology, 113, 179-182; (g) Hung TM, Na MK, Dat NT, Ngoc TM, Youn U, Kim HJ, Min BS, Lee JP, Bae KH. (2008) Cholinesterase inhibitory and anti-amnesic activity of alkaloids from Corydalis turtschaninovii. Journal of Ethnopharmacology, 119, 74-80; (h) Whiteley CG, Daya S. (1995) Protein ligand interactions. Part 5: Isoquinoline alkaloids as inhibitors of acetylcholinesterase from Electrophorus electricus. Journal of Enzyme Inhibition, 9, 285-294; (i) Khorana N, Markmee S, Ingkaninan K, Ruchirawat S, Kitbunnadaj R, Pullagurla MR. (2009) Evaluation of new lead for acetylcholinesterase inhibition. Medicinal Chemistry Research, 18, 231-241.
4.
HalbsguthC.H., MiessnerO., HäberleinH. (2003) Positive cooperation of protoberberine type 2 alkaloids from Corydalis cava on the GABAA binding site. Planta Medica, 69, 305–309; (b) Gleye J, Ahon A, Edouard S. (1974) Canadaline. New alkaloid from Hydrastis canadensis. Phytochemistry, 13, 675-676; (c) Shamma M, Salgar SS. (1973) Pallidine and corydine from Thalictrum dioicum. Phytochemistry, 12, 1505-1506; (d) de Wet H, van Herden FR, van Wyk BE. (2005) Alkaloids of Antizoma miersiana (Menispemaceae). Biochemical Systematics and Ecology, 33, 799-807; (e) Slavík J, Slavíková L. (1989) Alkaloids from Corydalis nobilis (L.) Pers. and C. intermedia (L.) Mérat. Collection of Czechoslovak Chemical Communications, 54, 2009-2019.
5.
GaleffiC., CometaM.F., TomassiniL., NicolettiM. (1997) Canadinic acid: an alkaloid from Hydrastis canadensis. Planta Medica, 63, 194; (b) Wu Y-R, Zhao Y-X, Liu Y-Q, Zhou J. (2007) Isoquinoline alkaloids from Corydalis taliensis. Zeitschrift für Naturforschung B: Biochemical Sciences, 62, 1199-1202; (c) Kim DK. (2002) Inhibitory effect of corynoline isolated from the aerial parts of Corydalis incisa on the acetylcholinesterase. Archives of Pharmacal Research, 25, 817-819; (d) Ma W, Fukushi Y, Tahara S. (1999) Fungitoxic alkaloids from Hokkaido Corydalis species. Fitoterapia, 70, 258-265; (e) Denisenko ON, Israilov IA, Yunusov MS. (1991) Alkaloids from Corydalis caucasica. Khimiya Priridnykh Soedinenii, 3, 439-440; (f) Zeng W, Liang W, Tu G. (1987) Chemical study of alkaloids from Corydalis bungeana. Planta Medica, 53, 418-420.
EllmanG.L., CourtneyK.D., AndresV., FeatherstoneR.M. (1961) A new rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology, 7, 88–95.
8.
SteckT.L., KantJ.A. (1974) Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. Methods in Enzymology, 31(Pt A), 172–180.
